Gauss

Recombinant Human IL-13 (carrier-free) 10 µg

Réf. UGAP : 3689336 Réf. Fournisseur : 571102 Réf. Constructeur : 571102
Recombinant Human IL-13 (carrier-free) 10 µg
Franco de port et d'emballage pour toutes les commandes supérieures à 80€ HT.

Produit ni repris ni échangé excepté en cas d’erreur du prestataire.
La quantité choisie doit être comprise entre 1 et 999 999.
Il ne reste que 0 exemplaires.

Points clés

Human IL-13 was initially cloned from cDNA libraries of activated T cells. IL-13 is an immunoregulatory cytokine secreted predominantly by activated T(H)2 cells, and it is a key mediator in the pathogenesis of allergic inflammation. IL-13 shares many functional properties with IL-4, and they share a common receptor subunit, the alpha subunit of the IL-4 receptor (IL-4Ralpha). IL-13 mediates its effects by interacting with a complex receptor system comprised of IL-4Ralpha and two IL-13 binding proteins, IL-13Ralpha1 and IL-13Ralpha2. Ligation of the IL-13 receptor complex results in signaling via the insulin receptor substrate (IRS)-1 and 2 and STAT-6 pathways. IL-13, like IL-4, is a cytokine produced by T(H)2 type helper T cells in response to signaling through the T cell antigen receptor and by mast cells and basophils upon cross-linkage of the high-affinity receptor for immunoglobulin E (IgE). IL-13 has been implicated in airway hypersensitivity and mucus hypersecretion, inflammatory bowel disease, and parasitic nematode expulsion.;

En savoir plus

Garantie

Garantie 0 Mois

Description

Human IL-13 was initially cloned from cDNA libraries of activated T cells. IL-13 is an immunoregulatory cytokine secreted predominantly by activated T(H)2 cells, and it is a key mediator in the pathogenesis of allergic inflammation. IL-13 shares many functional properties with IL-4, and they share a common receptor subunit, the alpha subunit of the IL-4 receptor (IL-4Ralpha). IL-13 mediates its effects by interacting with a complex receptor system comprised of IL-4Ralpha and two IL-13 binding proteins, IL-13Ralpha1 and IL-13Ralpha2. Ligation of the IL-13 receptor complex results in signaling via the insulin receptor substrate (IRS)-1 and 2 and STAT-6 pathways. IL-13, like IL-4, is a cytokine produced by T(H)2 type helper T cells in response to signaling through the T cell antigen receptor and by mast cells and basophils upon cross-linkage of the high-affinity receptor for immunoglobulin E (IgE). IL-13 has been implicated in airway hypersensitivity and mucus hypersecretion, inflammatory bowel disease, and parasitic nematode expulsion.;

Caractéristiques

Fournisseur
BioLegend Europe BV
Marque
BIOLEGEND
Référence fabricant
571102
Référence distributeur
571102
Vendu par
10 μg
Quantité
N/A
Lieu de fabrication
USA
Lieu de stockage
Pays-Bas ou USA
Soumis à carboglace
non
Classement dans le catalogue fournisseur
Recombinant Protein
Certification
RUO
Type d’application
culture cellulaire
Type de produit
protéine
Température de conservation (°C)
-20 ou -70 °C
Température de transport
Blue Ice
Organisme cible
Human
Source biologique
E. coli
Seuil de coupure des masses moléculaires MWCO
The 112 amino acid recombinant protein has a predicted molecular mass of 12,344 Da. The DTT-reduced and non-reduced protein migrate at approximately 9kDa by SDS-PAGE. Da
Concentration
10 and 25 µg sizes are bottled at 200 µg/mL. 100 µg size and larger sizes are lot-specific and bottled at the concentration indicated on the vial. To obtain lot-specific concentration, please enter the lot number in our online tools.
Pureté
Purity is >98%, as determined by Coomassie stained SDS-PAGE. %
Matière dangereuse
non
Code douanier
38220000
Classement NCBI
3596
Nomenclature Nacres
NA.77
Nomenclature CEA
SGP01
Nomenclature IRSN
273
Nomenclature INSERM
NA.NA77
Nomenclature CNRS
NA77
Nomenclature CHU
18.551
Nomenclature DGOS
LD11AOOO
Reprise en cas d’erreur client
non
Type d'échantillon
culture cellulaire